ArticleJournal of acquired immune deficiency syndromes (1999)2025
Inflammation, antiretroviral therapy continuation, and HIV disease progression in postpartum women with HIV.
Article in Journal of acquired immune deficiency syndromes (1999), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The HIV Reservoir and Immune Landscape Across the Life Course of Women: Implications for Cure Strategies.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
backgroundHigher levels of inflammation are associated with increased HIV disease progression, but data are lacking in postpartum women with HIV (WHIV), who generally have a distinct immune profile. Further, the impact of discontinuation of antiretroviral therapy (ART) on inflammation is not well understood for postpartum women. We studied the relationship of ART discontinuation, inflammation, and HIV disease progression in postpartum WHIV.
settingWe conducted a 1:3 case-control study (N=347) nested within a multi-country randomized trial comparing postpartum ART continuation vs. discontinuation in WHIV with WHO clinical stage 1 disease and who did not meet criteria for ART at the time. Median follow-up time was 97.1 weeks.
methodsCases were defined as WHIV who progressed to HIV disease stage 2 or greater during follow-up. Controls were selected using a risk set sampling strategy. Plasma levels of inflammatory biomarkers interleukin-6 (IL-6), interferon γ (IFNγ), tumor necrosis factor α (TNFα), intestinal fatty acid-binding protein (I-FABP), soluble CD14(sCD14) and CD163 (sCD163) before (i.e., baseline) and 4 weeks after randomization were measured using immunoassays. Weighted multivariable regression models assessed the association between inflammation with HIV disease progression, by randomization arm (ART continuation vs. discontinuation).
resultsPostpartum WHIV with higher levels of baseline I-FABP and persistently high levels of IFNγ and TNFα had increased hazards of HIV disease progression. Significantly larger increases in I-FABP and sCD14, and smaller increases in TNFα and sCD163 between baseline and week 4 were observed for postpartum participants who continued ART than among those who discontinued ART.
conclusionPostpartum WHIV with higher levels of immune biomarkers have increased hazards of HIV disease progression, suggesting an important role for inflammation in HIV treatment outcomes. Our results showed that continuation of ART compared to discontinuation had differential impacts on various immune markers, with the discontinuation results relevant in settings of poor adherence, or treatment interruption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.